Clinical trial

Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan

NCT00791830

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-04-01

PhasePHASE3

Study timeline

Study start (unknown)2009-04-01Date precision: month

Registry last updated2013-01-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Kidney Failure, Chronicunresolved

Interventions

IrbesartanDRUG · verified · RxNorm: irbesartan

Placebo matching irbesartan 150 mgDRUG

Sponsors & collaborators

University of Aarhuslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00791830 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.